Stay up-to-date with the latest news and resources from P&F Products & Features GmbH. As a leading heart valve manufacturer, we are committed to providing healthcare professionals with the knowledge and tools they need to deliver the best possible patient outcomes. Explore our resources, including the latest product innovations, in-depth case studies, and press releases covering recent company developments in the field of cardiology.
Publications
Bicaval TricValve Tricuspid Regurgitation: Late-Breaking PCR London Valves 2024
Source Data presented at PCR London Valves 2024 showed that caval valve implantation (CAVI) with the TricValve® system demonstrates an acceptable safety profile and significant clinical benefits in highly comorbid patients with severe
Tricuspid Regurgitation
In this short summary, Hon. Prof. Dr. Katharina Kiss talks about what you need to know about tricuspid regurgitation and current therapy options. Read Here
Interventional Treatment of Severe Tricuspid Regurgitation
In February 2018, a new article by Professor Lauten et al was published: Interventional Treatment of Severe Tricuspid Regurgitation. Early Clinical Experience in a Multicenter, Observational, First-in-Man Study. Transcatheter caval valve implantation
PRESS RELEASEs
P&F Products & Features GmbH wins esteemed Houska Prize for innovation and excellence
P&F Products & Features GmbH is proud to announce that it has been awarded the esteemed Houska Prize for outstanding innovation and excellence in the “Research and Development in Small and Medium-Sized
P&F Products and Features GmbH Appoints Dr. Roswitha Wolfram as Global Chief Medical Officer
Long-time healthcare executive to lead worldwide medical team P&F Products and Features GmbH (P&F), a leading global medical technology company focused on developing innovative minimally invasive cardiology solutions, today announced the appointment
Brazil Celebrates its 100th Implant of the TricValve System
Celebrating the 100th implantation of the Tricvalve system in Brazil! We are thrilled to announce the 100th transcatheter caval valve implant using TricValve’s innovative technology for patients with severe tricuspid regurgitation in
TricValve is Shortlisted for the Prestigious HOUSKA PRIZE 2025
P&F Products & Features, GmbH, Austria, is honored to be among the 15 short-listed finalists for the esteemed Houska Prize 2025 — Austria’s largest privately awarded prize fund for application-driven research (https://bcgruppe.at/en/houska-prize/). TricValve® – Transcatheter Bicaval Valve
P&F USA secures FDA approval for expansion of the TRICAV I study for severe Tricuspid Regurgitation
On December 19, 2024, the US Food and Drug Administration (FDA) approved the expansion of the TRICAV I study for the TricValve® Transcatheter Bicaval Valve System* from 15 patients to 50 patients
More minimally invasive treatment options available in S’pore for patients with leaky heart valve
SINGAPORE – Patients with leaky heart valve have more minimally invasive options to treat the condition, after two new procedures were introduced at the National Heart Centre Singapore (NHCS). Also known as
Vienna, February 24th 2022
P&F Products & Features goes U.S. – first implantation of the TricValve Transcatheter Bicaval Valves System
Vienna, May 18th 2021
P&F Products & Features GmbH gains CE Mark approval for TricValve® Transcatheter Bicaval Valves System
SINGAPORE, October 2021
THE STRAITS TIMES: More minimally invasive treatment options available in S´pore for patients with leaky heart valve
VIENNA, December 22nd 2020
TricValve® Transcatheter Bicaval Valves System granted Designation as Breakthrough Device by the U.S. Food and Drug Administration (FDA)
Short Cases
TricValve® Case: Salamanca
Performed in Spain at the University Hospital of Salamanca Dr. Javier Martín Moreiras MD, PhD Interventional Cardiologist and Associated Professor of Cardiology. University Hospital of Salamanca, Spain An 83-year-old woman with a
TricValve® Case: Madrid
Performed in Spain at Ramón y Cajal University Hospital Dr. Ángel Sánchez Recalde Head of Interventional Cardiology at Ramón y Cajal University Hospital in Madrid, Spain A 69-year-old male patient with symptoms
TricValve® Case: Saudi Arabia
Performed in the Saudi Arabia Prince Sultan Cardiac Centre Dr. Sondos Samargandy, Interventional Cardiologist and Head of the Cath Lab at Prince Sultan Cardiac Centre in Riyadh, Saudi Arabia A 64-year-old female